Ulrich Mrowietz
0000-0002-9539-0712
8 papers found
Refreshing results…
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial
ActiPso: definition of activity types for psoriatic disease: A novel marker for an advanced disease classification
CYP1A1 enzymatic activity influences skin inflammation via regulation of the AHR pathway
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment
Strategies to reduce stigma related to visible chronic skin diseases: a systematic review
Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus
ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study
Systemic Treatment with Fumaric Acid Esters in Six Paediatric Patients with Psoriasis in a Psoriasis Centre
Missing publications? Search for publications with a matching author name.